Company / CIK 0001156039
Elevance Health, Inc.
- Ticker
- ELV
- Size, estimated from filings
- Large cap ($10B – $200B)
- Insiders on file
- 10
- Members of Congress who traded it
- 2
- Federal contracts on record
- none matched
- Lobbying filings on record
- 28
- SEC filings
- EDGAR ↗
- Latest trade on record
- October 2, 2026
Elevance Health, Inc. (ELV) has 10 insiders on file who disclosed 18 transactions in the last 12 months (3 open-market buys, 7 sales, about $4.5M at reported prices), and 2 congressional trades in its stock are on record. No federal contract award that started in the last 180 days was found for a recipient with exactly this name, and 16 lobbying filings naming it as client report $5.1M in 2026.
Elevance Health, Inc. in charts
Who is trading this stock
Which people account for the buying and selling over the last 12 months?
8 people account for the disclosed buying and selling in Elevance Health, Inc. over the last 12 months; the most active is Kaye Mark with $1.6M.
Lobbying spend by quarter
How much has Elevance Health, Inc. reported spending on federal lobbying?
Elevance Health, Inc. reported $9.4M in lobbying over the last eight quarters, from filings matched by exact company name.
Insiders
| Name | Role | Rows | Bought | Sold | Last filed |
|---|---|---|---|---|---|
| Kaye Mark | EVP & CFO | 2 | 0 | 1 | October 6, 2026 |
| STRABLE-SOETHOUT DEANNA D | President and CEO | 1 | 0 | 0 | September 29, 2026 |
| Wessling Erin M | EVP & Chief Legal Officer | 2 | 0 | 2 | September 4, 2026 |
| Craig Ryan R | EVP & Chief HR Officer | 1 | 0 | 1 | September 4, 2026 |
| PERU RAMIRO G | Director | 1 | 1 | 0 | July 17, 2026 |
| BOUDREAUX GAIL | Director | 2 | 2 | 0 | July 17, 2026 |
| Dixon Robert L JR | Director | 1 | 0 | 1 | June 22, 2026 |
| Penczek Ronald W | CAO & Controller | 6 | 0 | 2 | June 15, 2026 |
| SCHULMAN AMY W | Director | 1 | 0 | 0 | May 22, 2026 |
| Schneider Ryan M. | Director | 1 | 0 | 0 | May 15, 2026 |
Rows are this company's Form 4 rows for each person. "Bought" and "sold" count open-market purchases (code P) and sales only. More in insider buying and insider selling.
Members of Congress who traded ELV
From periodic transaction reports that name the company's stock. Amounts are the sums of the ranges as filed. Every row is on the ELV page.
| Member | Seat | Trades | Bought | Sold | Range as filed | Latest |
|---|---|---|---|---|---|---|
| Alan Armstrong | Senator (OK), Republican | 1 | 1 | 0 | $1,001–$15K | March 27, 2026 |
| Markwayne Mullin | Senator (OK), Republican | 1 | 1 | 0 | $15K–$50K | December 29, 2025 |
Insider transactions
| Filer | Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Kaye Mark | ELV | Other A | October 2, 2026 | October 6, 2026 | 4d | 2,627 | — | — | Form 4 ↗ | ||
| Kaye Mark | ELV | Sell F | October 2, 2026 | October 6, 2026 | 4d | 4,161 | $386 | $1.6M | Form 4 ↗ | ||
| Craig Ryan R | ELV | Sell F | September 2, 2026 | September 4, 2026 | 2d | 144 | $406 | $58K | Form 4 ↗ | ||
| Wessling Erin M | ELV | Sell F | September 3, 2026 | September 4, 2026 | 1d | 255 | $415 | $106K | Form 4 ↗ | ||
| Wessling Erin M | ELV | Sell F | September 2, 2026 | September 4, 2026 | 2d | 94 | $406 | $38K | Form 4 ↗ | ||
| BOUDREAUX GAIL | ELV | Buy P | July 17, 2026 | July 17, 2026 | 0d | 2,045 | $368 | $753K | Form 4 ↗ | ||
| BOUDREAUX GAIL | ELV | Buy P | July 17, 2026 | July 17, 2026 | 0d | 680 | $366 | $249K | Form 4 ↗ | ||
| PERU RAMIRO G | ELV | Buy P | July 17, 2026 | July 17, 2026 | 0d | 1,000 | $366 | $366K | Form 4 ↗ | ||
| Penczek Ronald W | ELV | Sell S | June 12, 2026 | June 15, 2026 | 3d | 369 | $403 | $149K | Form 4 ↗ | ||
| Dixon Robert L JR | ELV | Sell S | June 11, 2026 | June 12, 2026 | 1d | 151 | $402 | $61K | Form 4 ↗ | ||
| Penczek Ronald W | ELV | Option / conversion M | May 19, 2026 | May 20, 2026 | 1d | 877 | — | — | derivative | Form 4 ↗ | |
| Penczek Ronald W | ELV | Option / conversion M | May 19, 2026 | May 20, 2026 | 1d | 654 | — | — | derivative | Form 4 ↗ | |
| Penczek Ronald W | ELV | Sell S | May 19, 2026 | May 20, 2026 | 1d | 1,531 | $403 | $617K | Form 4 ↗ | ||
| Penczek Ronald W | ELV | Option / conversion M | May 19, 2026 | May 20, 2026 | 1d | 877 | $311 | $273K | Form 4 ↗ | ||
| Penczek Ronald W | ELV | Option / conversion M | May 19, 2026 | May 20, 2026 | 1d | 654 | $271 | $177K | Form 4 ↗ | ||
| Schneider Ryan M. | ELV | Other A | May 13, 2026 | May 15, 2026 | 2d | 563 | — | — | Form 4 ↗ | ||
| SCHULMAN AMY W | ELV | Other A | May 13, 2026 | May 15, 2026 | 2d | 563 | — | — | Form 4 ↗ | ||
| STRABLE-SOETHOUT DEANNA D | ELV | Other A | May 13, 2026 | May 15, 2026 | 2d | 563 | — | — | Form 4 ↗ |
Federal contracts (USAspending, awards started in the last 180 days)
No contract award starting in the last 180 days was found for a recipient named exactly "Elevance Health, Inc.". Subsidiaries and differently-spelled recipients are not matched — search contracts.
Lobbying (Senate LDA, as client)
| Period | Registrant | Primary issue | Amount | Source |
|---|---|---|---|---|
| 2026 Q3 | TIBER CREEK GROUP | Medicare/Medicaid | $90,000 | LDA ↗ |
| 2026 Q3 | MEHLMAN CONSULTING, INC. | Health Issues | $90,000 | LDA ↗ |
| 2026 Q3 | CONTINENTAL STRATEGY, LLC | Health Issues | $75,000 | LDA ↗ |
| 2026 Q3 | ALB SOLUTIONS | Health Issues | $60,000 | LDA ↗ |
| 2026 Q2 | ELEVANCE HEALTH, INC. | Health Issues | $2,290,000 | LDA ↗ |
| 2026 Q2 | MEHLMAN CONSULTING, INC. | Health Issues | $90,000 | LDA ↗ |
| 2026 Q2 | TIBER CREEK GROUP | Medicare/Medicaid | $90,000 | LDA ↗ |
| 2026 Q2 | CONTINENTAL STRATEGY, LLC | Health Issues | $75,000 | LDA ↗ |
| 2026 Q2 | ALB SOLUTIONS | Health Issues | $60,000 | LDA ↗ |
| 2026 Q2 | CAPITOL HILL CONSULTING GROUP | Medicare/Medicaid | $60,000 | LDA ↗ |
| 2026 Q1 | ELEVANCE HEALTH, INC. | Health Issues | $1,720,000 | LDA ↗ |
| 2026 Q1 | MEHLMAN CONSULTING, INC. | Health Issues | $90,000 | LDA ↗ |
| 2026 Q1 | TIBER CREEK GROUP | Medicare/Medicaid | $90,000 | LDA ↗ |
| 2026 Q1 | CONTINENTAL STRATEGY, LLC | Health Issues | $75,000 | LDA ↗ |
| 2026 Q1 | ALB SOLUTIONS | Health Issues | $60,000 | LDA ↗ |
| 2026 Q1 | CAPITOL HILL CONSULTING GROUP | Medicare/Medicaid | $60,000 | LDA ↗ |
| 2025 Q4 | ELEVANCE HEALTH, INC. | Health Issues | $1,530,000 | LDA ↗ |
| 2025 Q4 | MEHLMAN CONSULTING, INC. | Pharmacy | $90,000 | LDA ↗ |
| 2025 Q4 | TIBER CREEK GROUP | Medicare/Medicaid | $90,000 | LDA ↗ |
| 2025 Q4 | CONTINENTAL STRATEGY, LLC | Health Issues | $75,000 | LDA ↗ |
| 2025 Q4 | ALB SOLUTIONS | Health Issues | $60,000 | LDA ↗ |
| 2025 Q4 | CAPITOL HILL CONSULTING GROUP | Medicare/Medicaid | $60,000 | LDA ↗ |
| 2025 Q3 | ELEVANCE HEALTH, INC. | Health Issues | $2,040,000 | LDA ↗ |
| 2025 Q3 | MEHLMAN CONSULTING, INC. | Health Issues | $90,000 | LDA ↗ |
| 2025 Q3 | TIBER CREEK GROUP | Medicare/Medicaid | $90,000 | LDA ↗ |
| 2025 Q3 | CONTINENTAL STRATEGY, LLC | Health Issues | $75,000 | LDA ↗ |
| 2025 Q3 | ALB SOLUTIONS | Health Issues | $60,000 | LDA ↗ |
| 2025 Q3 | CAPITOL HILL CONSULTING GROUP | Medicare/Medicaid | $60,000 | LDA ↗ |
Related companies
Companies whose stock was traded by the same people who traded ELV, by number of filers in common. It shows overlap in public filings and nothing else.
- Dell Technologies Inc. DELL 2 filers in common
- Meta Platforms, Inc. META 2 filers in common
- INTUIT INC. INTU 2 filers in common
- ADOBE INC. ADBE 2 filers in common
- Salesforce, Inc. CRM 2 filers in common
- ELI LILLY & Co LLY 2 filers in common
- ServiceNow, Inc. NOW 2 filers in common
- NVIDIA CORP NVDA 2 filers in common
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Lobbying disclosure reports Reports are due about 20 days after each quarter ends.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| Senate eFD, periodic transaction reports | 2 | 2 | January 16, 2026 | July 21, 2026 | Senate eFD search |
| SEC EDGAR, Form 4 | 11 | 18 | May 15, 2026 | October 6, 2026 | Form 4 list on EDGAR |
| Lobbying disclosure filings | 28 filings | — | — | — | LDA.gov search |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Insiders and their transactions come from SEC EDGAR Form 4 filings for this issuer. Contracts and lobbying are matched by exact normalized name (suffixes like Inc./Corp. ignored) to USAspending recipients and LDA clients — a conservative match that misses subsidiaries on purpose. See methodology and corrections.
Not investment advice. Public records shown as filed; no recommendation is made or implied.